{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:51:02Z","timestamp":1790509862990,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.mcn.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T01:24:27Z","timestamp":1456363467000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients"],"prefix":"10.1016","volume":"74","author":[{"given":"Alessandro","family":"Arosio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gessica","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Rodriguez-Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Grana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gerardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lunetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Tremolizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2016.02.002_bb0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/BJ20100131","article-title":"Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression","volume":"430","author":"Aude-Garcia","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.mcn.2016.02.002_bb0010","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/092986707782793862","article-title":"The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure","volume":"14","author":"Beghi","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mcn.2016.02.002_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.cellbio.14.1.167","article-title":"Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins","volume":"14","author":"Black","year":"1998","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.mcn.2016.02.002_bb0020","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1080\/14660820050515647","article-title":"Problems in shortening the time to confirmation of ALS diagnosis: lessons from the 1st Consensus Conference, Chicago, May 1998","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"10.1016\/j.mcn.2016.02.002_bb0025","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/brain\/awt164","article-title":"Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression","volume":"136","author":"Bruneteau","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.mcn.2016.02.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032632","article-title":"Genetic biomarkers for ALS disease in transgenic SOD1(G93A) mice","volume":"7","author":"Calvo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2016.02.002_bb0035","doi-asserted-by":"crossref","first-page":"33752","DOI":"10.1074\/jbc.M706268200","article-title":"The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming","volume":"282","author":"Cohen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2016.02.002_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1096\/fj.08-115931","article-title":"The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity","volume":"23","author":"Cohen","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.mcn.2016.02.002_bb0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-010-0786-7","article-title":"Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations","volume":"121","author":"De Marco","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2044-5040-3-7","article-title":"Kr\u00fcppel-like factor 6 (KLF6) promotes cell proliferation in skeletal myoblasts in response to TGF\u03b2\/Smad3 signaling","volume":"3","author":"Dionyssiou","year":"2013","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.mcn.2016.02.002_bb0055","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1126\/science.1122511","article-title":"Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number","volume":"311","author":"Flavell","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mcn.2016.02.002_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0896-6273(03)00191-0","article-title":"Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis","volume":"38","author":"Gong","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2016.02.002_bb0065","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1128\/MCB.25.6.2273-2287.2005","article-title":"Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors","volume":"25","author":"Gr\u00e9goire","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0070","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1074\/jbc.M509471200","article-title":"Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation","volume":"281","author":"Gr\u00e9goire","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2016.02.002_bb0075","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/00001756-200006050-00037","article-title":"GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis","volume":"11","author":"Grundstr\u00f6m","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.mcn.2016.02.002_bb0080","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival","volume":"5","author":"Henkel","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mcn.2016.02.002_bb0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410370413","article-title":"Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease","volume":"37","author":"Ikeda","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0090","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/NEN.0b013e3181ddd404","article-title":"Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis","volume":"69","author":"Janssen","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exnr.2002.8011","article-title":"Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis","volume":"177","author":"K\u00fcst","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0100","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1523\/JNEUROSCI.0534-12.2012","article-title":"Members of the myocyte enhancer factor 2 transcription factor family differentially regulate Bdnf transcription in response to neuronal depolarization","volume":"32","author":"Lyons","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2016.02.002_bb0105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1126\/science.286.5440.785","article-title":"Neuronal activity-dependent cell survival mediated by transcription factor MEF2","volume":"286","author":"Mao","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.mcn.2016.02.002_bb0110","doi-asserted-by":"crossref","first-page":"14400","DOI":"10.1073\/pnas.260501497","article-title":"Activation of the myocyte enhancer factor-2 transcription factor by calcium\/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5","volume":"97","author":"McKinsey","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2016.02.002_bb0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0959-437X(00)00224-0","article-title":"Control of muscle development by dueling HATs and HDACs","volume":"11","author":"McKinsey","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.mcn.2016.02.002_bb0120","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1093\/hmg\/ddq385","article-title":"Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy","volume":"19","author":"Menzies","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2016.02.002_bb0125","doi-asserted-by":"crossref","first-page":"19884","DOI":"10.1074\/jbc.M700770200","article-title":"Singar1, a novel RUN domain-containing protein, suppresses formation of surplus axons for neuronal polarity","volume":"282","author":"Mori","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2016.02.002_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025545","article-title":"Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells","volume":"6","author":"Nardo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2016.02.002_bb0135","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","article-title":"A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III)","volume":"52","author":"No authors listed","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2016.02.002_bb0140","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1523\/JNEUROSCI.0233-09.2009","article-title":"A retrograde neuronal survival response: target-derived neurotrophins regulate MEF2D and bcl-w","volume":"29","author":"Pazyra-Murphy","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2016.02.002_bb0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-6-29","article-title":"Cu, Zn-superoxide dismutase 1 (SOD1) is a novel target of Puromycin-sensitive aminopeptidase (PSA\/NPEPPS): PSA\/NPEPPS is a possible modifier of amyotrophic lateral sclerosis","volume":"6","author":"Ren","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcn.2016.02.002_bb0150","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03077.x","article-title":"Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice","volume":"93","author":"Ryu","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2016.02.002_bb0155","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00702-010-0446-z","article-title":"Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease","volume":"117","author":"Sala","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.mcn.2016.02.002_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/17482968.2011.611139","article-title":"A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis","volume":"13","author":"Sala","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.mcn.2016.02.002_bb0165","doi-asserted-by":"crossref","first-page":"846725","DOI":"10.1155\/2013\/846725","article-title":"Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition","volume":"2013","author":"Sala","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.mcn.2016.02.002_bb0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2013.12.017","article-title":"Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease","volume":"1546","author":"Sala","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2016.02.002_bb0175","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1523\/JNEUROSCI.3609-11.2012","article-title":"Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons","volume":"32","author":"Salma","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2016.02.002_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10571-011-9743-9","article-title":"Functional gene expression analysis of tissue-specific isoforms of Mef2c","volume":"32","author":"Sekiyama","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0185","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/360757a0","article-title":"Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section","volume":"360","author":"Sendtner","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2016.02.002_bb0190","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.1122513","article-title":"A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation","volume":"311","author":"Shalizi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mcn.2016.02.002_bb0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0161-5890(98)00058-3","article-title":"Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes","volume":"35","author":"Swanson","year":"1998","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/21678421.2012.746990","article-title":"Exploring limits of neuropsychological screening in ALS: the FAB problem","volume":"14","author":"Tremolizzo","year":"2013","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"10.1016\/j.mcn.2016.02.002_bb0205","doi-asserted-by":"crossref","DOI":"10.1159\/000441916","article-title":"BDNF serum levels with respect to multidimensional assessment in Amyotrophic Lateral Sclerosis","author":"Tremolizzo","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.mcn.2016.02.002_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.247","article-title":"Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways","volume":"5","author":"Valle","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mcn.2016.02.002_bb0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2009.09.105","article-title":"Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper\/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS)","volume":"1305","author":"Volkening","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2016.02.002_bb0220","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1471-4159.2007.04606.x","article-title":"Brain-derived neurotrophic factor stimulates the transcriptional and neuroprotective activity of myocyte-enhancer factor 2C through an ERK1\/2-RSK2 signaling cascade","volume":"102","author":"Wang","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2016.02.002_bb0225","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni.1609","article-title":"Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation","volume":"9","author":"Wilker","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0230","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1101\/gad.6.9.1783","article-title":"Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors","volume":"6","author":"Yu","year":"1992","journal-title":"Genes Dev."},{"key":"10.1016\/j.mcn.2016.02.002_bb0235","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","article-title":"Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis","volume":"8","author":"Zhao","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.mcn.2016.02.002_bb0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","article-title":"TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome","volume":"273","author":"Zhao","year":"2015","journal-title":"Exp. Neurol."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104474311630015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104474311630015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T01:00:06Z","timestamp":1572397206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104474311630015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":48,"alternative-id":["S104474311630015X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2016.02.002","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}